These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 6041608)

  • 1. [A new therapeutic possibility in Rh-isoimmune hemolytic disease of the newborn. The use of Rh-positive blood based on the study of free anti-D antibody in the newborn infant. (Preliminary note)].
    Pataki L; Kaiser G; Virág I; Román F
    Orv Hetil; 1967 Feb; 108(8):352-4. PubMed ID: 6041608
    [No Abstract]   [Full Text] [Related]  

  • 2. Free anti-D antibody in haemolytic disease of the newborn due to Rh-isoimmunization.
    Pataki L; Kaiser G; Román F; Virág I
    Acta Paediatr Acad Sci Hung; 1969; 10(3):229-64. PubMed ID: 5393080
    [No Abstract]   [Full Text] [Related]  

  • 3. Haemolytic disease of the newborn due to Rh-isoimmunization: the role of free anti-D antibodies in bilirubin rebound.
    Pataki L
    Acta Paediatr Acad Sci Hung; 1970; 11(3):219-29. PubMed ID: 5004392
    [No Abstract]   [Full Text] [Related]  

  • 4. [Rh factor: anti-D isoimmunization and its therapeutic possibilities].
    Tucci G; Teofili MT
    Clin Ter; 1967 Dec; 43(6):567-89. PubMed ID: 4979582
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment with immunodepressant drugs in neonatal hemolytic disease caused by Rh isoimmunization (preliminary note)].
    De Luca P; Merlino G
    Arch Ostet Ginecol; 1980; 85(3):169-73. PubMed ID: 6802113
    [No Abstract]   [Full Text] [Related]  

  • 6. [A case of hemolytic disease of the newborn caused by materno-fetal isoimmunization against factor c(hr') (preliminary note)].
    De Luca P
    Arch Ostet Ginecol; 1980; 85(3):175-7. PubMed ID: 6802114
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical follow-up studies on late prognosis of Rh-related hemolytic disease of the newborn. VII. Indications for exchange transfusion in Rh-incompatibility].
    Schneeweiss B
    Padiatr Grenzgeb; 1970; 9(3):208-17. PubMed ID: 4997628
    [No Abstract]   [Full Text] [Related]  

  • 8. [The possibility of the use of Rh positive blood in the treatment of haemolytic disease of the newborn caused by Rh isoimmunization].
    Pataki L; Román F; Kaiser G; Virág I
    Orv Hetil; 1969 Aug; 110(34):1967-70. PubMed ID: 4981554
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hemolytic disease of newborn caused by anti-c antibody].
    Tóth A; Vágvölgyi E; Trézli I
    Orv Hetil; 1982 Aug; 123(32):1983-4. PubMed ID: 6815609
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prophylaxis of hemolytic disease of newborn].
    Kietlińska-Kmiolek Z
    Wiad Lek; 1971 Apr; 24(8):755-60. PubMed ID: 4996047
    [No Abstract]   [Full Text] [Related]  

  • 11. Rh hemolytic disease of the newborn.
    Page S
    Neonatal Netw; 1989 Jun; 7(6):31-41. PubMed ID: 2499756
    [No Abstract]   [Full Text] [Related]  

  • 12. [Intrauterine transfusion in severe hemolytic disease caused by Rh sensitization].
    Lampé L; Kelemen J; Komáromy B; Mihály G
    Orv Hetil; 1970 Nov; 111(44):2598+. PubMed ID: 5488133
    [No Abstract]   [Full Text] [Related]  

  • 13. Rhesus anti-E, anti-c antibodies as a cause of hemolytic disease of the newborn.
    Nair PM; Sabarinathan K; Jayaprakash PA; Vijayalekshmi
    Indian Pediatr; 1983 Sep; 20(9):681-4. PubMed ID: 6427106
    [No Abstract]   [Full Text] [Related]  

  • 14. [The number of neonates treated with exchange transfusion for hemolytic disease due to Rh isoimmunization before and after the administration of anti-Rho (D) immunoglobulin prophylactically].
    Hodr R
    Cesk Gynekol; 1986 Mar; 51(2):95-6. PubMed ID: 3006930
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hemolytic disease of the newborn].
    Nakayama K; Fujisawa S
    Rinsho Byori; 1967; ():Suppl 14:61-70. PubMed ID: 4969613
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hemolytic disease of the newborn and therapeutic anti-allergic antibodies].
    Guimbretière J; Dehorne M; Guimbretière L
    Rev Fr Transfus; 1969; 12(1):Suppl:395+. PubMed ID: 4987784
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diagnostic and therapeutic possibilities in hemolytic disease of the newborn].
    Colucci G
    Friuli Med; 1965; 20(2):149-73. PubMed ID: 5892007
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
    Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Our experience with exchange transfusion in hemolytic disease of the newborn].
    Racheva B; Marinova N
    Akush Ginekol (Sofiia); 1965; 4(5):471-6. PubMed ID: 5894278
    [No Abstract]   [Full Text] [Related]  

  • 20. Blocked D phenomenon, a rare condition with Rh D haemolytic disease of newborn - a case report.
    Sulochana PV; Rajesh A; Mathai J; Sathyabhama S
    Int J Lab Hematol; 2008 Jun; 30(3):244-7. PubMed ID: 18205842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.